Mead Johnson Nutrition CO (NYSE:MJN)‘s stock had its “speculative buy” rating reiterated by stock analysts at Canaccord Genuity in a research note issued to investors on Wednesday, StockTargetPrices.com reports.

A number of other analysts have also issued reports on the company. Zacks Investment Research lowered Mead Johnson Nutrition CO from a “hold” rating to a “sell” rating in a report on Friday, April 28th. Wells Fargo & Company lowered Mead Johnson Nutrition CO from an “outperform” rating to a “market perform” rating and set a $89.00 target price for the company. in a report on Monday, April 3rd. BMO Capital Markets restated a “hold” rating and issued a $90.00 target price on shares of Mead Johnson Nutrition CO in a report on Thursday, June 15th. BidaskClub upgraded Mead Johnson Nutrition CO from a “sell” rating to a “hold” rating in a report on Wednesday, June 14th. Finally, Susquehanna Bancshares Inc set a $90.00 target price on Mead Johnson Nutrition CO and gave the company a “hold” rating in a report on Saturday, April 1st. Two analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $84.83.

Mead Johnson Nutrition CO (MJN) opened at 89.98 on Wednesday. The stock has a 50 day moving average price of $89.62 and a 200-day moving average price of $84.34. Mead Johnson Nutrition CO has a 12-month low of $69.25 and a 12-month high of $94.40.

Mead Johnson Nutrition CO (NYSE:MJN) last announced its quarterly earnings data on Thursday, April 27th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.79 by $0.01. The company had revenue of $883.50 million for the quarter, compared to analyst estimates of $911.63 million. During the same quarter last year, the company posted $0.87 EPS. Mead Johnson Nutrition CO’s revenue was down 8.2% on a year-over-year basis. On average, equities research analysts anticipate that Mead Johnson Nutrition CO will post $3.30 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 5th. Shareholders of record on Tuesday, June 20th were given a dividend of $0.4125 per share. This represents a $1.65 annualized dividend and a yield of 1.83%. The ex-dividend date was Friday, June 16th. Mead Johnson Nutrition CO’s payout ratio is 51.72%.

TRADEMARK VIOLATION WARNING: This report was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was stolen and reposted in violation of US and international trademark & copyright law. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/07/05/mead-johnson-nutrition-company-nysemjn-earns-speculative-buy-rating-from-canaccord-genuity.html.

Large investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in shares of Mead Johnson Nutrition CO by 2.2% in the first quarter. Vanguard Group Inc. now owns 12,206,341 shares of the company’s stock valued at $1,087,341,000 after buying an additional 266,416 shares in the last quarter. BlackRock Inc. increased its stake in shares of Mead Johnson Nutrition CO by 2,802.8% in the first quarter. BlackRock Inc. now owns 11,394,361 shares of the company’s stock valued at $1,015,011,000 after buying an additional 11,001,837 shares in the last quarter. State Street Corp increased its stake in shares of Mead Johnson Nutrition CO by 0.5% in the first quarter. State Street Corp now owns 7,709,238 shares of the company’s stock valued at $686,744,000 after buying an additional 36,271 shares in the last quarter. York Capital Management Global Advisors LLC acquired a new stake in shares of Mead Johnson Nutrition CO during the first quarter valued at about $309,688,000. Finally, Morgan Stanley increased its stake in shares of Mead Johnson Nutrition CO by 181.8% in the first quarter. Morgan Stanley now owns 1,939,244 shares of the company’s stock valued at $172,748,000 after buying an additional 1,251,041 shares in the last quarter. 88.40% of the stock is currently owned by institutional investors.

About Mead Johnson Nutrition CO

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

Stock Target Prices

Analyst Recommendations for Mead Johnson Nutrition CO (NYSE:MJN)

Receive News & Ratings for Mead Johnson Nutrition CO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition CO and related companies with MarketBeat.com's FREE daily email newsletter.